Regulation of TLR9 dependent DNA Immune complex mediated cell activation by High Mobility Group Box Protein 1 (HMGB1) and Receptor for Advanced Glycation End products (RAGE)

被引：0
|
作者：
Tian, Jane [1 ]
Avalos, Ana Maria [2 ]
Chen, Bo [1 ]
Fitzgerald, Katherine A. [3 ]
Sirois, Cherilyn [3 ]
Golenbock, Douglas [3 ]
Marshak-Rothstein, Ann [2 ]
Crow, Mary K. [4 ]
Audoly, Laurent [1 ]
Kiener, Peter A. [1 ]
Latz, Eicke [3 ]
Coyle, Anthony J. [1 ]
机构：
[1] Medimmune Inc, Gaithersburg, MD 20878 USA
[2] Boston Univ, Sch Med, Boston, MA 02118 USA
[3] Univ Massachusetts, Sch Med, Worcester, MA USA
[4] Hosp Special Surg, New York, NY 10021 USA
来源：
JOURNAL OF IMMUNOLOGY | 2007年 / 178卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
128.35
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Heparan Sulfate Is Essential for High Mobility Group Protein 1 (HMGB1) Signaling by the Receptor for Advanced Glycation End Products (RAGE)
    Xu, Ding
    Young, Jeffrey
    Song, Danyin
    Esko, Jeffrey D.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (48) : 41736 - 41744
  • [2] EVIDENCE FOR PARTICIPATION OF HIGH MOBILITY GROUP BOX 1 PROTEIN (HMGB1) IN ACTIVATION OF RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS (RAGE) AND TOLL-LIKE RECEPTOR (TLR) SYSTEMS IN WOMEN WITH SEVERE PREECLAMPSIA
    Baumbusch, Margaret A.
    Buhimschi, Catalin S.
    Zhao, Guomao
    Thung, Stephen
    Oliver, Emily A.
    Buhimschi, Irina A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (06) : S217 - S217
  • [3] RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) IS NOT REQUIRED FOR INDUCTION OF LIPOTEICHOIC ACID (LTA) TOLERANCE BY HIGH MOBILITY GROUP BOX 1 (HMGB1)
    Robert, Stephen
    Sjodin, Hanna
    Fink, Mitchell
    Aneja, Rajesh
    CRITICAL CARE MEDICINE, 2009, 37 (12) : A55 - A55
  • [4] Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma
    Li, Lingzhao
    Beeraka, Narasimha M.
    Xie, Linsen
    Dong, Li
    Liu, Junqi
    Wang, Lei
    DISCOVER ONCOLOGY, 2022, 13 (01)
  • [5] Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma
    Lingzhao Li
    Narasimha M. Beeraka
    Linsen Xie
    Li Dong
    Junqi Liu
    Lei Wang
    Discover Oncology, 13
  • [6] High motility group box 1 (HMGB1) protein and its receptor for advanced glycation end products (RAGE) expression in chronic rhinosinusitis without nasal polyps
    Dzaman, Karolina
    Zagor, Mariola
    Molinska-Glura, Marta
    Krzeski, Antoni
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2015, 53 (01) : 70 - 78
  • [7] Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review
    Austin Huy Nguyen
    Detty, Shannon Q.
    Agrawal, Devendra K.
    ANTICANCER RESEARCH, 2017, 37 (01) : 1 - 7
  • [8] High-mobility Group B1 (HMGB1) and Receptor for Advanced Glycation End-products (RAGE) Expression in Canine Lymphoma
    Sterenczak, Katharina A.
    Joetzke, Alexa E.
    Willenbrock, Saskia
    Eberle, Nina
    Lange, Sandra
    Junghanss, Christian
    Nolte, Ingo
    Bullerdiek, Joern
    Simon, Daniela
    Escobar, Hugo Murua
    ANTICANCER RESEARCH, 2010, 30 (12) : 5043 - 5048
  • [9] Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)
    van Beijnum, Judy R.
    Buurman, Wim A.
    Griffioen, Arjan W.
    ANGIOGENESIS, 2008, 11 (01) : 91 - 99
  • [10] Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)
    Judy R. van Beijnum
    Wim A. Buurman
    Arjan W. Griffioen
    Angiogenesis, 2008, 11 : 91 - 99
12345